Vectorite Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	25.71	30.6	25.32	27.87	39.2
Short-Term Investments	144.9	-	-	179.7	154.5
Trading Asset Securities	-	154.3	178.36	5.94	45.68
Cash & Short-Term Investments	170.61	184.9	203.67	213.52	239.38
Cash Growth	-7.73%	-9.21%	-4.61%	-10.80%	167.28%
Accounts Receivable	2.77	6.11	5.64	5.59	1.11
Other Receivables	0.42	0.46	0.06	0.16	0.76
Receivables	3.19	6.56	5.69	5.75	1.87
Inventory	14.97	14.79	10.04	4.83	7.24
Prepaid Expenses	3.1	2.22	3.73	7.97	1.84
Other Current Assets	0.01	-	-	-	-
Total Current Assets	191.89	208.47	223.13	232.06	250.32
Property, Plant & Equipment	172.7	172.4	178.33	182.73	190.7
Long-Term Investments	142.62	15.5	23.33	23.4	24.24
Other Intangible Assets	0.41	6.04	21.81	22.54	22.54
Other Long-Term Assets	1.93	10.36	5.51	5.1	4.85
Total Assets	509.56	412.78	452.1	465.82	492.65
Accounts Payable	0.92	1.14	1.2	3.18	2.72
Accrued Expenses	-	6.05	7.02	4.85	6.39
Current Unearned Revenue	4.51	5.31	3.13	5.25	5.89
Other Current Liabilities	10.76	2.33	1.38	2.27	1.61
Total Current Liabilities	16.19	14.83	12.73	15.55	16.61
Long-Term Leases	0.21	-	-	-	-
Long-Term Unearned Revenue	8.07	8.16	8.51	8.93	9.09
Other Long-Term Liabilities	0.01	0.21	0.01	0.01	0.01
Total Liabilities	24.48	23.2	21.25	24.49	25.71
Common Stock	437.71	437.71	437.71	721.4	721.4
Additional Paid-In Capital	11.67	11.67	11.67	101.14	101.14
Retained Earnings	49.52	-46.65	-6.6	-373.17	-346.75
Comprehensive Income & Other	-14.19	-13.56	-12.34	-8.48	-9.29
Total Common Equity	484.71	389.16	430.44	440.9	466.51
Minority Interest	0.37	0.42	0.41	0.44	0.43
Shareholders' Equity	485.08	389.58	430.85	441.34	466.94
Total Liabilities & Equity	509.56	412.78	452.1	465.82	492.65
Total Debt	0.21	-	-	-	-
Net Cash (Debt)	170.4	184.9	203.67	213.52	239.38
Net Cash Growth	-7.84%	-9.21%	-4.61%	-10.80%	167.28%
Net Cash Per Share	3.88	4.23	4.65	4.88	5.57
Filing Date Shares Outstanding	43.66	43.77	43.77	43.77	43.77
Total Common Shares Outstanding	43.66	43.77	43.77	43.77	43.77
Working Capital	175.7	193.64	210.4	216.52	233.71
Book Value Per Share	11.10	8.89	9.83	10.07	10.66
Tangible Book Value	484.3	383.12	408.63	418.36	443.97
Tangible Book Value Per Share	11.09	8.75	9.34	9.56	10.14
Land	-	59.45	59.45	59.45	59.45
Buildings	-	157.27	155.36	155.36	155.36
Machinery	-	60.92	59.99	55.23	54.34
Leasehold Improvements	-	2.5	2.5	2.5	2.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.